
Prof. Dr. Stylianos Michalakis
Project 4, Spokesperson
Stylianos Michalakis is Professor for Ocular Gene Therapy at the Eye Hospital of the LMU Hospital. His group focuses on improving AAV vector technologies and developing and translating AAV-based gene therapies for ophthalmic diseases. He is named as inventor in 7 pending or active AAV vector patents and is a scientific co-founder of the LMU gene therapy start-up ViGeneron GmbH.